Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 4
2017 2
2018 3
2019 3
2020 4
2021 3
2022 8
2023 6
2024 6
2025 3
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.
Smirnov RA, Cantoni C, Lee K, Agnihotri RA, Axtell RC, Salter A, Lancia S, Paley MA, Hayward B, Korich J, Evans E, Pardo G, Obeidat AZ, Stuve O, Bar-Or A, Artyomov MN, Cross AH, Edelson BT, Wu GF. Smirnov RA, et al. Among authors: pardo g. Neurol Neuroimmunol Neuroinflamm. 2026 May;13(3):e200565. doi: 10.1212/NXI.0000000000200565. Epub 2026 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2026. PMID: 41990287 Free PMC article. Clinical Trial.
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.
Hauser SL, Freedman MS, Nakahara J, Paling D, de Seze J, Li J, Abeyewickreme A, Wu M, Sullivan R, Pardo G, Montalban X, Wiendl H. Hauser SL, et al. Among authors: pardo g. Mult Scler Relat Disord. 2026 Jan;105:106886. doi: 10.1016/j.msard.2025.106886. Epub 2025 Nov 25. Mult Scler Relat Disord. 2026. PMID: 41380509 Free article. Clinical Trial.
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Mackay M, Wagner CA, Pinckney A, Cohen JA, Wallace ZS, Khosroshahi A, Sparks JA, Lord S, Saxena A, Caricchio R, Kim AH, Kamen DL, Koumpouras F, Askanase AD, Smith K, Guthridge JM, Pardo G, Mao-Draayer Y, Macwana S, McCarthy S, Sherman MA, Daneshfar Hamrah S, Veri M, Walker S, York K, Tedeschi SK, Wang J, Dziubla GE, Castro M, Carroll R, Narpala SR, Lin BC, Serebryannyy L, McDermott AB, Barry WT, Goldmuntz E, McNamara J, Payne AS, Bar-Or A, Khanna D, James JA. Mackay M, et al. Among authors: pardo g. JCI Insight. 2025 Nov 25;11(1):e191266. doi: 10.1172/jci.insight.191266. Online ahead of print. JCI Insight. 2025. PMID: 41289027 Free PMC article.
Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension.
Cerqueira JJ, Berthele A, Cree BAC, Filippi M, Pardo G, Pearson OR, Traboulsee A, Ziemssen T, Vollmer T, Bernasconi C, Mandel CR, Kulyk I, Chognot C, Raposo C, Schneble HM, Thanei GA, Incera E, Havrdová EK. Cerqueira JJ, et al. Among authors: pardo g. Neurology. 2025 Feb 25;104(4):e210142. doi: 10.1212/WNL.0000000000210142. Epub 2025 Jan 30. Neurology. 2025. PMID: 39883906 Free PMC article. Clinical Trial.
Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females.
Cordeiro B, Ahn JJ, Gawde S, Ucciferri C, Alvarez-Sanchez N, Revelo XS, Stickle N, Massey K, Brooks DG, Guthridge JM, Pardo G, Winer DA, Axtell RC, Dunn SE. Cordeiro B, et al. Among authors: pardo g. Cell Metab. 2024 Oct 1;36(10):2298-2314.e11. doi: 10.1016/j.cmet.2024.07.017. Epub 2024 Aug 20. Cell Metab. 2024. PMID: 39168127 Free PMC article.
Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion.
Gawde S, Siebert N, Ruprecht K, Kumar G, Ko RM, Massey K, Guthridge JM, Mao-Draayer Y, Schindler P, Hastermann M, Pardo G, Paul F, Axtell RC. Gawde S, et al. Among authors: pardo g. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200268. doi: 10.1212/NXI.0000000000200268. Epub 2024 Jun 17. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38885457 Free PMC article.
Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.
Anderson E, Powell M, Yang E, Kar A, Leung TM, Sison C, Steinberg R, Mims R, Choudhury A, Espinosa C, Zelmanovich J, Okoye NC, Choi EJ, Marder G, Narain S, Gregersen PK, Mackay M, Diamond B, Levy T, Zanos TP, Khosroshahi A, Sanz I, Luning Prak ET, Bar-Or A, Merrill J, Arriens C, Pardo G, Guthridge J, James J, Payne A, Utz PJ, Boss JM, Aranow C, Davidson A. Anderson E, et al. Among authors: pardo g. JCI Insight. 2024 Jun 4;9(13):e180750. doi: 10.1172/jci.insight.180750. JCI Insight. 2024. PMID: 38833310 Free PMC article.
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, Morrow SA, Ann Picone M, Pardo G, Zarif M, Gudesblatt M, Nicholas JA, Smith A, Hunter S, Newman S, AbdelRazek MA, Hoti I, Riolo J, Silva D, Fuchs TA, Dwyer MG, Hb Benedict R. Zivadinov R, et al. Among authors: pardo g. Neuroimage Clin. 2024;42:103609. doi: 10.1016/j.nicl.2024.103609. Epub 2024 Apr 27. Neuroimage Clin. 2024. PMID: 38718640 Free PMC article.
40 results